Capgemini SE

Accenture plc

The company has engaged consulting agencies to implement its new product in the work of corporate clients

IPO-ready OpenAI has found a way to strengthen itself in the corporate marketplace

Novo Nordisk A/S

Eli Lilly and Company

A key objective of the trial was to confirm that Novo was as effective as a competitor's product, Eli Lilly

Novo's failure to test a weight loss drug has sparked a sell-off in the Danish market

Amazon.com, Inc.

Tesla, Inc.

Ares Management Corporation

KKR & Co. Inc.

NVIDIA Corporation

"You can't bet against Trump, if he wants to impose duties, he'll find a way to do it," the analyst believes

US stocks decline amid Trump's 'confusion' over duties

The European Union has warned of its readiness to freeze the ratification process of the trade agreement with the United States and asked the administration of US President Donald Trump for further clarification on America's new duty policy, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-02-23/eu-set-to-freeze-us-trade-deal-approval-over-trump-tariff-risk">writes</a>.

No choice: EU threatens to halt approval of US trade deal over Trump's duties

Lucid Group, Inc.

Investors should avoid buying shares of electric vehicle maker Lucid in the hope of a rebound, <a href="https://www.fool.com/investing/2026/02/22/should-you-buy-lucid-while-its-below-10/">argues</a>&nbsp;Motley Fool contributor Chris Neiger. Over the past three years, the company’s stock has fallen about 90%, a decline that may make the shares look attractive ahead of the planned launch of a lower-priced EV model. But that appeal is misleading, the analyst believes, the core issue being that Lucid remains deeply unprofitable.

Motley Fool analyst warns against temptation to buy EV maker Lucid on the dip

Apple Inc.

According to a new study, companies with the worst reputations are bypassing the market while leaders are making losses

Apple broke the stereotype of low returns on "everyone's favorite" stock. What is the threat?

Entry-level positions in investment banking allow you to earn six-figure sums, but require working 24/7

Can an analyst get 9 hours of sleep? Wall Street has closed a lawsuit over 24/7 work hours

Hermes International Societe en commandite par actions

NIKE, Inc.

Some limited luxury handbags and sneakers are appreciating faster than stocks in the main U.S. index S&amp;P 500, the platform FashioNica found out. The goods of French brand Hermes, for example, including the world-famous Birkin bags, are particularly quoted. Analysts call luxury goods assets and compare them, for example, to gold.

Handbags vs. AI boom: luxury goods posted better price gains than stocks in the S&amp;P 500

The U.S. Supreme Court's ruling that most of the import duties imposed by U.S. President Donald Trump are <a href="https://oninvest.com/article/verhovnyj-sud-ssa-otmenil-global-nye-posliny-prezidenta-trampa-rynki-rastut">illegal</a> and his response - imposing an additional global levy of 15% - is playing into the hands of emerging markets. They have been on the periphery of international investors' attention for many years, but now their indices are strongly outperforming developed markets.

Emerging market indices outperformed developed markets. Asia and Latin America attract investors 

Hims & Hers Health, Inc.

U.S. telehealth platform and online pharmacy Hims &amp; Hers Health will <a href="https://investors.hims.com/news/news-details/2026/Hims--Hers-Announces-Agreement-to-Acquire-Eucalyptus-Accelerating-Its-Vision-to-Become-the-Leading-Global-Consumer-Health-Platform/default.aspx">acquire</a>&nbsp;Australian peer Eucalyptus. The deal comes as the company <a href="https://finance.yahoo.com/news/hims-hers-1-2-billion-165104901.html">seeks</a>&nbsp;to reshape investor perceptions after U.S. regulators <a href="https://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulatorhttps://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulatorhttps://en.oninvest.com/article/novo-shares-rise-cheap-copy-of-its-drug-fails-to-survive-criticism-from-us-regulator">criticized</a>&nbsp;it over the sale of a copycat of Novo Nordisk’s obesity drug Wegovy and the Danish drugmaker filed a lawsuit.

Hims & Hers to buy Australian peer Eucalyptus amid GLP-1 regulatory, legal pressure

Netflix, Inc.

Warner Bros. Discovery, Inc.

Vanda Pharmaceuticals Inc.

Bentley Systems, Incorporated

Smurfit Westrock Plc

International Paper Company

Packaging Corporation of America

Alphabet Inc.

CoreWeave, Inc.

Blue Owl Capital Inc.

Celsius Holdings, Inc.

Comfort Systems USA, Inc.

Live Nation Entertainment, Inc.

AppLovin Corporation

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: tariff policy in the spotlight

Berkshire Hathaway Inc.

Caterpillar Inc.

Microsoft Corporation

Waste Management, Inc.

Canadian National Railway Company

Bill Gates' fund <a href="https://www.sec.gov/Archives/edgar/data/1166559/000110465926016458/0001104659-26-016458-index.htm">made</a> only two changes to its portfolio last quarter: reducing stakes in Microsoft and Berkshire Hathaway, according to its report on Form 13F. The investor's strategy remains concentrated: the fund has shares of 23 companies under management, but more than 80% of its capital is allocated to just five issuers.

Iran